{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:27:50Z","timestamp":1792207670765,"version":"4.4.0"},"reference-count":53,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1764,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1365-3083.2010.02463.x","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T19:54:33Z","timestamp":1283543673000},"page":"540-547","source":"Crossref","is-referenced-by-count":190,"title":["Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR\u2212\/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma"],"prefix":"10.1111","volume":"72","author":[{"given":"M. K.","family":"Brimnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Vangsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gimsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. E.","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. M.","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1200\/JCO.1999.17.1.208","article-title":"Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells","volume":"17","author":"Corradini","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0b013e3181c51f0d","article-title":"Novel immunotherapies","volume":"15","author":"Yi","year":"2009","journal-title":"Cancer J"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2004.04984.x","article-title":"Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma","volume":"125","author":"Brown","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/14653240410006004","article-title":"Impaired circulating myeloid DCs from myeloma patients","volume":"6","author":"Do","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2141.2004.04971.x","article-title":"Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro","volume":"125","author":"Orsini","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.leu.2403474","article-title":"Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate","volume":"18","author":"Boissel","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.0007-1048.2001.03318.x","article-title":"Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia","volume":"116","author":"Bourguin-Plonquet","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood.V98.13.3750","article-title":"Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment","volume":"98","author":"Mohty","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.bjc.6601243","article-title":"Altered maturation of peripheral blood dendritic cells in patients with breast cancer","volume":"89","author":"Della","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB13|cit13","first-page":"483","article-title":"Decreased antigen presentation by dendritic cells in patients with breast cancer","volume":"3","author":"Gabrilovich","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00262-003-0485-5","article-title":"Dendritic cells are dysfunctional in patients with operable breast cancer","volume":"53","author":"Satthaporn","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1593\/neo.05442","article-title":"A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer","volume":"7","author":"Pinzon-Charry","year":"2005","journal-title":"Neoplasia"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjc.6604018","article-title":"Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer","volume":"5","author":"Pinzon-Charry","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2006.03037.x","article-title":"Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma","volume":"144","author":"Brimnes","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmg.39.8.537","article-title":"Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"39","author":"Wildin","year":"2002","journal-title":"J Med Genet"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-230X(10)07003-X","article-title":"Regulatory T cells in cancer","volume":"107","author":"Mougiakakos","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1053\/j.gastro.2007.03.102","article-title":"Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients","volume":"132","author":"Fu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.11618","article-title":"CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression","volume":"98","author":"Sasada","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1158\/1078-0432.CCR-05-1244","article-title":"The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer","volume":"11","author":"Wolf","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","article-title":"In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma","volume":"107","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2005-08-3101","article-title":"Dysfunctional T regulatory cells in multiple myeloma","volume":"107","author":"Prabhala","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00915255","article-title":"Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function","volume":"6","author":"Pilarski","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.2003.04375.x","article-title":"Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma","volume":"121","author":"Maecker","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","article-title":"Immunodeficiency and immunotherapy in multiple myeloma","volume":"138","author":"Pratt","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB36|cit36","first-page":"1787","article-title":"Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck","volume":"8","author":"Hoffmann","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","article-title":"Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target","volume":"16","author":"Chauhan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin\u2019s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells","volume":"11","author":"Alvaro","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB42|cit42","first-page":"4404","article-title":"Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers","volume":"9","author":"Ichihara","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00262-005-0107-5","article-title":"Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients","volume":"55","author":"Wolf","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","article-title":"Cutting edge: TGF-beta induces a regulatory phenotype in CD4+","volume":"172","author":"Fantini","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.4049\/jimmunol.172.10.6003","article-title":"Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants","volume":"172","author":"Cobbold","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","article-title":"Role of transforming growth factor-beta in hematologic malignancies","volume":"107","author":"Dong","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/eji.200324552","article-title":"Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells","volume":"34","author":"Verhasselt","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","article-title":"Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/eji.200425093","article-title":"Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells","volume":"35","author":"Fiore","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB52|cit52","first-page":"1755","article-title":"Clinical significance of defective dendritic cell differentiation in cancer","volume":"6","author":"Almand","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-3083.2010.02463.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Az-Montero","year":"2009","journal-title":"Cancer Immunol Immunother"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.2010.02463.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-3083.2010.02463.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T12:33:55Z","timestamp":1625574835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.2010.02463.x"}},"subtitle":["Immune Impairment in Patients with Multiple Myeloma"],"short-title":[],"issued":{"date-parts":[[2010,11,2]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.2010.02463.x","relation":{},"ISSN":["0300-9475"],"issn-type":[{"value":"0300-9475","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,2]]}}}